PTPI Stock Price has plummeted, is it ready to bounce? URGENT

Petros Pharmaceuticals PTPI stock price is down –4% in the last 5 days & volume is up 7%, but is it over for this breakout stock?

In this in depth report, I look at 5 KPIs: Technical Analysis, Volume, News Cycle, Fundamentals & awareness campaigns.

Before we get started, I like being methodical and easy to understand so I have developed a ranking system for my stocks. I call it, Alexander Goldman’s “HOT Stock Ranking!”

CA:XBC stock price

The official heat level for PTPI is, a 🔥🔥2 out of 4

Before I get ahead of myself and just jump right into this exciting breakout stock, I wanted to introduce myself.

Hello 🙋‍♂️ My name is Alexander Goldman. I have been trading small cap stocks, breakout stocks and trending stocks for 20 years now. I established the coveted HOT Stock Reporting system.

To find out more about my story, CLICK HERE


[thrive_leads id=’28419′]

Petros Pharmaceuticals Company Information

Company Name: Petros Pharmaceuticals Inc

Ticker: PTPI

Exchange: NASDAQ

Website: https://www.petrospharma.com/

Petros Pharmaceuticals Company Summary:

Petros Pharmaceuticals, Inc. engages in men’s health therapeutics. It is involved in sales, marketing, regulatory and medical affairs, finance, trade relations, pharmacovigilance, market access relations, manufacturing, and distribution. It operates through the Prescription Medications and Medical Devices segments. The Prescription Medications segment handles Stendra, a FDA approved PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction, and H100, a topical formulation candidate for the treatment of acute Peyronie’s disease. The Medical Devices segment consists of vacuum erection devices. The company was founded on May 14, 2020 and is headquartered in New York, NY.EBML stock price is due to News?

PTPI stock price is due to News?

  • Announced the pursuit of the 505(b)(2) pathway for early stage asset, H-100 for the treatment of Peyronie’s Disease
  • Initiated sponsored research agreement with Massachusetts General Hospital to evaluate incorporating the use of a tissue-specific oxygenation sensor with the goal of monitoring and understanding the success of Erectile Device Therapy.
  • Reported positive results of a Phase 2 label comprehension study to initiate process for STENDRA(R) prescription erectile dysfunction medication to support the process for designation as over -the-counter treatment
  • Engaged with celebrity physician, Dr. Drew Pinsky to provide patient education about erectile dysfunction and branded STENDRA messaging
  • Announced an agreement with a leading U.S. based global contract manufacturer for STENDRA

PTPI

PTPI Stock Price HOT Stock Grade:

PTPI is, a 🔥🔥2 out of 4 . Here are my takeaways on it and why it is just a 3 out of 4.

PTPI Trading Volume

The volume, the normal trading volume is established by the previous 30 days of trading and this stock is trading at an increase of 7% over the average. Normally, this indicates a higher demand in the stock or a sell off (selling pressure).

Trading 101: volume is measured in the number of shares traded. Traders look to volume to determine liquidity and combine changes in volume with technical indicators to make trading decisions. So, let’s take a look at the technical indicators.

PTPI Technicals

The technical analysis “chart reading”, this stock is down -3% on the 5 day chart and the overall trend for the long term chart, the 1 month, is down -31%. We are still waiting for the bottom. I imagine good news should be coming soon, pay attention and bookmark it.

Trading 101: Technical indicators are technical tools that help in analyzing the movement in the stock prices whether the ongoing trend is going to continue or reverse. It helps the traders to make entry and exit decisions of a particular stock. Technical indicators can be leading or lagging indicators.

PTPI News Cycle

The news, there is no significant news.

PTPI Fundamentals

The fundamentals, how a company is doing financially can be a serious KPI and there is no exciting financial filings associated with this stock.

Trading 101: Fundamental trading is a method where a trader focuses on company-specific events to determine which stock to buy and when to buy it. Trading on fundamentals is more closely associated with a buy-and-hold strategy rather than short-term trading.

PTPI Awareness

Marketing efforts “Awareness Campaigns” Just like advertising a prroduct is important, advertising a publicly traded company during a news cycle is critical for the stock price of a company.

I have found marketing efforts around the investor awareness of this company. So, I have awarded this stock a 2 out of 4. Do you agree? Write me a line at [email protected]

Again, two heads are better than one, let’s work together to have the best trading year of our lives!

To receive my 🔥🔥🔥🔥 HOT stock as a thank you for joining our FREE newsletter, sign up today.

To find out more about my story, CLICK HERE

👇 Sign up for our newsletter to get the latest 🔥🔥🔥🔥 HOT stocks and we can compare notes!👇


[thrive_leads id=’28419′]

Petros PTPI bounce play alert–

Petros PTPI is possibly about to explode again as the short position increases as PPS is ticking up. Pay attention to PTPI as this stock may skyrocket

Petros Pharma PTPI company summary

Company Name: Petros Pharmaceuticals, Inc. 

Ticker: (PTPI)

Exchange: NASDAQ

Website: https://www.petrospharma.com/

Petros PTPI Company Summary:

Petros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men’s health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men’s health issues, including, but not limited to, erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie’s disease, hormone health, and substance use disorders.

Why is it down?

The NEWS:

Petros PTPI released incredible news that is found below late in 2021.

Petros  reported positive over-the-counter (OTC) draft label comprehension study results for its erectile dysfunction (ED) Drug STENDRA® (avanafil). This Pivotal Label Comprehension Study was designed to assess comprehension of a draft STENDRA® Drug Facts Label intended for OTC use. 

What did the say, “The label comprehension study is a key component of our plans to help expand access for STENDRA beyond the prescription model, and to make 
The first “potentially the first prescription-grade ED medication to become available over-the-counter in the United States.” EVER?!?

PTPI 5 Day Chart

PTPI

PTPI 5 Day Analysis

This stock is fully consolidated so I expect the moment they issue positive news, it will skyrocket.

PTPI 1 Day Chart

1 Day Analysis

You can clearly see thin the one day that there is a slight bearish trend. Get ready traders because I’ve been following PTPI for a while and I believe it is getting ready for another move as long as the stock has good news attached to it to get it going.

Petros Pharmaceuticals PTPI short squeeze

Petros Pharmaceuticals PTPI is possibly about to explode again as the short position increases as PPS is ticking up. Pay attention to PTPI as this stock may skyrocket

Petros PTPI company summary

Company Name: Petros Pharmaceuticals, Inc. 

Ticker: (PTPI)

Exchange: NASDAQ

Short Squeeze Article: HERE

Petros PTPI Company Summary:

Petros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men’s health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men’s health issues, including, but not limited to, erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie’s disease, hormone health, and substance use disorders.

Why is it red HOT?

The NEWS:

Petros  reported positive over-the-counter (OTC) draft label comprehension study results for its erectile dysfunction (ED) Drug STENDRA® (avanafil). This Pivotal Label Comprehension Study was designed to assess comprehension of a draft STENDRA® Drug Facts Label intended for OTC use. 

What did the say, “The label comprehension study is a key component of our plans to help expand access for STENDRA beyond the prescription model, and to make 
The first “potentially the first prescription-grade ED medication to become available over-the-counter in the United States.” EVER?!?

The Short Squeeze

Look HERE at our buddies over at Fintel.io. This stock has a big short position and could go crazy!

PTPI 5 Day Chart

PTPI 5 Day Analysis

The convergence point is coming Traders! All signs are pointing to a short squeeze! It is coming late Friday or Monday! Once PTPI breaks $2.82 & $2.90, boom like a rocket ship!

PTPI 1 Day Chart

1 Day Analysis

You can clearly see the $2.82 resistance. Get ready traders because I’ve been following PTPI for a while and I can hear the juice machine warming up for the BIG squeeze.

Skip to content